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1. In~~uction 
Phosphofructokinase (ATP:D-fructose 6-P-l 
phosphotransferase, EC 2.7.1 .l l), one of the key 
enzymes of the glycolytic pathway, is an allosteric 
enzyme subjected to a complex regulation by various 
metabolites, i.e., fructose 1,6-P, fl], ATP [2] AMP 
and ADP [3], citrate f4], NHf [5] and SOi- [6]. 
In addition to the already known muscle type 
(M-type) and liver type (L-type) forms [7], we have 
recently proven the existence of a third basic form of 
phosphofructo~nase, called ~broblast (of F) type 
enzyme 181. This newly discovered isozyme is pre- 
dominantly expressed in fibroblasts, platelets, brain, 
lymphocytes and kidney. The homotetramer F4 has 
been purified to homogeneity from human platelets 
f93. 
The goal of this work was to characterize, on a 
kinetic point of view, human F4 phosphofructokinase 
as compared to the other forms, L4 and Mq. 
2. Materials and methods 
The substrates, auxiliary enzymes and coenzymes 
were from Boehringer-Mannheim or Serva-Heidelberg. 
Enzyme activities were measured at 30°C in a Gilford 
(Model 252) spectrophotometer. 
2.1. Ptm@xztion of ~h~s~ho~~~oki~~s~ 
The homotetramers M4 (from muscle), LG (from 
red cells) and F4 (from platelets) were purified as in 
[9,10]. For red cells and platelets these homotetramers 
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were first separated from the L-M and L-F hybrids 
by DEAE-cellulose chromatography [9,11]. The last 
step, was, in all the cases, an affinity chromatography 
on Dextran blue-Sepharose 4B column with elective 
elution by ADP and fructose 6-P [9,10]. 
Before use, phosphofructokinase and auxiliary 
enzymes were extensively dialyzed against a50 mM 
Tris-HCl buffer (pH 8)/S mM &mercaptoethanol/ 
1 mM (NH& S04/0.01 mM fructose 1,6-P,. The 
kinetic detestations were performed at pH 7 (in 
50 mM glycyl-glycine buffer) and pH 8 (in 50 mM 
Tris-HCl buffer). In both cases the reaction mixture 
contained 1 mM (NH& SOJO. mglml bovine 
albumin/5 mM dithiotreitol/ 100 mM KCl/0.5 mM 
Mg C12/0.2 mM NADHIO.5 IU/ml aldolase/lO IUfml 
triose phosp~te i~merase~O.5 IUfml glycerol3- 
phosphate dehydrogenase. Activation by NH&l was 
studied using the aforementioned reactive mixture 
slightly modified in that (NH&SO4 was omitted and 
KC1 was only 5 mM. 
After 10 min incubation at 3O”C, the reaction was 
started by MgATP2-. The ATPfMg” ratio was 1: 3, 
Mgp being provided as the MgCl, salt. In the fast 
experiments, in fact, we systematically employed 2 
different*ATP/Mg* ratios (1: 3 and 1: l), and did not 
find any difference between the results obtained. 
The kinetic behaviour towards fructose 6-P was 
studied over 0.025-4 mM, at 4 constant concentra- 
tions of MgATP’- (0.25,0.5,1 and 2 mM). The 
kinetic behaviour towards MgATP2- was determined 
over 0.01-3 mM, at a constant 1 mM fructose 6-P. 
Activation by AMP and glucose 1,6-P, and inhibi- 
tion by citrate were studied at a constant 0.5 mM 
fructose 4-P and I mM MgATP’-. AMP was varied 
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from 0.002-0.2 mM, glucose 1,6-P, from 
0.001-0.2 mM and that of citrate from 0.1-l mM. 
3. Results 
All the kinetic determinations were performed in 
triplicate, at both pH 7 and pH 8. We always found 
the same type of kinetic differences between the iso- 
zymes at pH 7 and pH 8, only more pronounced at 
pH 7. Since it is indeed known that the regulatory 
properties of phosphofructokinase are maximum at 
acidic pH [l-6], we shall only report here the results 
obtained at pH 7. 
3.1. Kinetics towanis fiztctose 6-P 
Figure 1 and table 1 show that the maximal 
Fig.1. Kinetics towards fructose 6-P; MgATP*; 0.5 mM 
(pH 7). (-A-A-) M, phosphofructokinase; (-e-e-) L4 
phosphofructokinase; (*-•) F, phosphofructokinase. Vmax 
was appreciated from a Lineweaver-Burk plot at high 
fructose 6-P concentration. For further details, see section 2. 
cooperativity was observed for M4 (Hill coefficient 
-3-4) and L4 (Hill coefficient 1.4-3.4) while the 
positive homotropic interactions were by far less 
pronounced for F4 (Hill coefficient <l S). 
Cooperativity strongly depended on ATP concen- 
tration for La, slightly for F4 and not at all for Mq. 
In the same way, K,., for fructose 6-P increased with 
MgATP’- concentration for L-type and F-type 
enzymes, but not for muscle-type phosphofructo- 
kinase. The F-type isozyme exhibited a higher 
apparent affinity for fructose 6-P than the other 
forms. 
3.2. ATP inhibition (fig.2) 
ATP acts as a substrate of the reaction, but it 
Fig.2. ATP inhibition; fructose 6-P, 1 mM (pH 7). The results 
are expressed as a fraction of the maximal activity measured. 
See legends to fig.1. 
Table 1 
Kinetics towards fructose 6-P 
M-type L-type F-type 
K Hill 
(r%) coeff. 
K 
(rz, 
Hill K Hill 
coeff. (rzi) coeff. 
0.25 1.2 3.0 0.9 1.4 0.27 0.8 
0.5 1.8 3.6 1.4 2.0 0.62 1.2 
1 1.3 3.9 1.5 2.7 0.84 1.3 
2 2.0 3.5 2.3 3.4 1.2 1.5 
The figures given in this table represent he results of typical experiments. Similar 
results were obtained by using a ATP/Mg* ratio of 1: 1 (instead of 1: 3). Hill 
coefficient and K,,, for fructose 6-P were determined from a Hillplot; maximal 
velocity was calcuiated from a Lineweaver-Burk plot 
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Fig.3. Citrate inhibition; fructose 6-P, 0.5 mM; MgATP”-, 
1 mM (pH 7). See legends to fig.l,2. 
becomes inhibitor as its concentration rises [2]. It is 
known for several years that L isozyme is more 
inhibited than M4 [7]. We show here that it is also 
more inhibited than Fq. Compared to Ma, ATP inhi- 
bition of F4 began at lower ATP concentration and 
was of a similar extent. 
3.3. Citrate inhibition (fig.31 
As expected [4], the isozyme which was the most 
strongly inhibited by citrate was muscle-type phospho- 
fructokinase, followed by liver-type nzyme. F4 was 
the least inhibited form. 
3.4. Glucose 1,6-P, activation (fig.4) 
Since it is not possible to study fructose 1 ,6-PZ 
activation using the coupled assay with aldolase, triose 
phosphate isomerase and glycerol phosphate dehydro- 
genase, we studied the influence of glucose 1 ,6-P2 on 
the different phosphofructokinase i ozymes. 
Glucose 1 ,6PZ has been shown to be able to 
activate phosphofructokinase in a similar fashion to 
fructose 1 ,6-PZ [ 12- 141. Activation by glucose 
1 ,6-PZ was maximum for M4 phosphofructokinase 
and intermediate for 4. F4 phosphofructokinase was 
totally insensitive to glucose 1 ,6-PZ. 
t I I I I 
0.05 01 a2mM 
GLUCOSE 1,&P, 1 
Fig.4. Glucose 1,6-P, activation; fructose 6-P, 0.5 mM; 
MgATP'- , 1 mM @H 7). See legends to fig.1 -3. 
3.5. AMP activation (fig.5) 
As in [3], we found that AMP was a strong 
activator of Ld and M4 enzymes. By contrast, F4 
phosphofructokinase was practically insensitive to 
AMP. 
3.6. Influence of NH+, 
Under the conditions reported in section 2, 
maximal activation by NH4Cl was 12-l 5-fold for both 
Lg and M4 phosphofructokinases and only 3-fold for 
Fq; it was obtained for approximately the same 
NH4C1 concentration (30 mM). 
Fig.5. AMP activation; fructose 6-P, 0.5 mM; Mg ATP’-, 
1 mM (pH 7). See legends to fgl-4. 
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4. Discussion 
This work describes for the first time some kinetic 
characteristics of F4 phosphofructokinase which 
represents he third, newly discovered basic form of 
phosphofructokinase in man. Its main kinetic features 
are: practically hyperbolic kinetic for fructose 6-P 
(except at high ATP concentration); absence of 
activation by AMP and glucose 1,6-P* ; slight activa- 
tion by NH:; slight inhibition by ATP and citrate. 
These studies were made with F4 phosphofructo- 
kinase purified from human platelets. We could 
therefore ask whether this unexpected behaviour was 
due to the environment or to particular properties of 
these cells. We also studied the kinetics of enzyme 
from human fibroblasts and some malignant tissues 
which have been proven to contain a high amount of 
F4 form [8] and we found the same kinetic properties, 
in particular hyperbolic kinetics towards fructose 6-P 
(experiments not shown). Therefore we think that 
these properties are intrinsic of the F4 isozyme. 
Non-allosteric phosphofructokinases have already 
been described in some microorganisms. A non- 
allosteric enzyme in normal Luctobacillus plantamm 
has been shown in [ 151. In E. coli, the main species 
of phosphofructokinase are allosteric, but mutants 
with non-allosteric enzymes have been described 
[16,17]. 
However, in mammals no example of such a type 
of phosphofructokinase i  known so far. It cannot be 
said that F4 is a ‘non-allosteric’ enzyme, since it is 
regulated by citrate, ATP and exhibits slight positive 
homotropic effects towards fructose 6-P at high ATP 
concentration. Its regulatory properties, however, 
Seem clearly less developed than those of M4 and La 
enzymes ince it is less regulated by almost all the 
allosteric effecters studied here than these latter 
phosphofructokinases; it isin this way that it can be 
compared to the non-allosteric enzymes from the 
aforementioned microorganisms. 
It is assumed that phosphofructokinase plays an 
essential role in regulation of glycolysis, and it is 
worth noting that the regulatory forms are expressed 
in cells in which this metabolic pathway has to be 
accurately regulated, e.g., muscle and liver. By con- 
trast, the isozyme F4 is found in relatively undif- 
ferentiated cells (e.g., fibroblasts or malignant cells), 
or in cells in which glycolysis is not known to play a 
major physiological role (e.g., platelets or lymphocytes). 
222 
In conclusion, besides the 2 well characterized 
muscle-type and liver-type forms of phosphofructo- 
kinase, which exhibit complex regulatory properties, 
a third basic form exists in man (and probably in 
mammals). This third isozyme can be regarded as a 
poor regulatory enzyme as compared to the other 
phosphofructokinase forms. 
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